PRESCRIP-TEC client-related factors (CRF) for cervical cancer screening

The project implements an innovative approach in cervical cancer screening, including direct treatment and follow-up, for women in resource-poor or hard-to-reach settings, by improving availability, accessibility, acceptability and quality of services.

PRESCRIP-TEC focuses on implementation research into secondary prevention of cervical cancer in different settings in four countries over three continents: Bangladesh and India in Asia, Uganda in Africa, and Slovakia in Eastern Europe. The project builds on interventions with promising or proven effectiveness including cost-effectiveness: - hrHPV based screening is cost-effective when adequate coverage is reached. - Self-swab for hrHPV leads to higher uptake of screening compared to sampling by clinicians. - Visual inspection with acetic acid (VIA) is an approved screening method by the WHO and is part of the national cervical cancer prevention programme in Uganda, Bangladesh, India; in India AI to support VIA screening was shown to be effective in detecting VIA positive lesions.